U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750275) titled 'Safety and Economics of Parenchymal Transection in Minimally Invasive Liver Surgery' on July 20.
Brief Summary: LIVER-MIND 2 is a multicentre, observational, retrospective registry coordinated by the SICE HPB and Minimally Invasive Surgery Working Group, enrolling consecutive adults undergoing elective minimally invasive (laparoscopic, robotic or hybrid) liver resection between January 2021 and December 2025 across >=15 high-volume or dedicated centres (target >30 centres).
Study Start Date: Jan. 01, 2021
Study Type: OBSERVATIONAL
Condition:
Liver Surgery
MINIMALLY INVASIVE LIVER SURGERY
Liver Neoplasm
Recruitment Status: ENROLL...